SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059493
Filing Date
2024-05-14
Accepted
2024-05-14 16:02:35
Documents
68
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krro-20240331.htm   iXBRL 10-Q 1901145
2 EX-31.1 krro-ex31_1.htm EX-31.1 16918
3 EX-31.2 krro-ex31_2.htm EX-31.2 16800
4 EX-32.1 krro-ex32_1.htm EX-32.1 9337
  Complete submission text file 0000950170-24-059493.txt   7355027

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT krro-20240331.xsd EX-101.SCH 1346317
71 EXTRACTED XBRL INSTANCE DOCUMENT krro-20240331_htm.xml XML 957985
Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39062 | Film No.: 24944126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)